ASPP1 and ASPP2 enhance the pro-apoptotic function of p53, promoting cell death in response to damage, while iASPP acts as a negative regulator, inhibiting apoptosis and thus potentially contributing to tumor progression (13, 14). Here, PPP1R13B is linked to neoplasm.